Treatment Option Overview
Factors to be considered in planning therapy for vaginal cancer are:
- Stage, size, and location of the lesion.
- Presence or absence of the uterus.
- Whether there has been prior pelvic radiation therapy.
In a large series of women studied retrospectively for 30 years, 50% had undergone hysterectomy prior to the diagnosis of vaginal cancer.[1] In this posthysterectomy group, 31 of 50 (62%) women developed cancers limited to the upper third of the vagina. In women who had not previously undergone hysterectomy, upper vaginal lesions were found in only 17 of 50 (34%) women. The lymphatics may drain to pelvic or inguinal nodes or both, depending on tumor location, and consideration should be given to these areas in treatment planning. The proximity of the vagina to the bladder or rectum limits treatment options and increases complications involving these organs. For patients with carcinoma of the vagina in its early stages, standard treatment applied by gynecologic oncologists or radiation oncologists is highly effective. For patients with stages III and IVA disease, radiation therapy alone is standard. For patients with stage IVB disease, current therapy is inadequate, and no established anticancer drugs can be considered standard treatment. Considering the rarity of such patients, they should be considered candidates for clinical trials using anticancer drugs and/or radiosensitizers to attempt to improve survival or local control.
Physicians Interacting With Family Caregivers
Patients and caregivers may present with different needs, making it difficult to decide whose needs take priority.[1] This situation is especially common when it comes to truth-telling, with family members asking the health care team to keep bad news a secret from the cancer patient, or vice versa. Communication With Caregivers Cultural differences can profoundly affect communication with the patient and family. For example, some Asian Americans believe that talking about death or dying...
Read the Physicians Interacting With Family Caregivers article > >
Information about ongoing clinical trials is available from the NCI Web site.
References:
WebMD Public Information from the National Cancer Institute

